DIACOMIT® approved by FDA

DIACOMIT® approved by FDA

Diacomit® (stiripentol) has been approved by the US FDA for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam. The approval came on August 20, 2018.

Read more

Previous

Next